(19)
(11) EP 2 295 132 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 2 (W2 B1)

(48) Corrigendum issued on:
15.03.2017 Bulletin 2017/11

(45) Mention of the grant of the patent:
10.08.2016 Bulletin 2016/32

(21) Application number: 10014044.1

(22) Date of filing: 14.05.2010
(51) International Patent Classification (IPC): 
B01D 63/02(2006.01)
B01D 69/08(2006.01)
A61M 1/36(2006.01)
 B01D 69/02(2006.01)
B01D 67/00(2006.01)

(54)

Antithrombogenic hollow fiber membranes, potting material and blood tubing

Antithrombogene Hohlfasermembranen, Vergussmaterial und Schlauchverbindungen für Blut

Membranes à fibre creuse, materiau d'enrobage et tubulures pour le sang antithrombogène

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 15.05.2009 US 178861 P

(43) Date of publication of application:
16.03.2011 Bulletin 2011/11

(62) Application number of the earlier application in accordance with Art. 76 EPC:
10754844.8

(73) Proprietor: Interface Biologics Inc.
Toronto, Ontario M5G 1L7 (CA)

(72) Inventors:
  • Mullick, Sanjoy
    Brampton Ontario L7A 1Y5 (CA)
  • Chang, Weilun
    Toronto Ontario M4Y 3C4 (CA)
  • Esfand, Roseita
    Mississauga Ontario L5K 1Y3 (CA)
  • Steedman, Mark
    Toronto Ontario M5M 3L1 (CA)
  • Chen, Hanje
    Toronto Ontario M2M 2E3 (CA)

(74) Representative: Lahrtz, Fritz 
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68
81675 München
81675 München (DE)


(56) References cited: : 
EP-A1- 0 332 261
EP-A1- 0 894 823
WO-A1-98/34718
 EP-A1- 0 615 778
EP-A2- 0 068 509
WO-A1-2004/056459
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).